Dan Hammerly
Interim Vice President of Investor Relations
Replay available
Quest Diagnostics Incorporated (NYSE: DGX) Q1 2026 earnings conference call, held 2026-04-21. Replay captured from the company's public earnings webcast.

Interim Vice President of Investor Relations
Chairman, Chief Executive Officer and President
Chief Financial Officer
Analyst, Laring Partners
Analyst, Evercore ISI
Analyst, Citi
Analyst, CEO of Securities
Analyst, Nefan
Watch the replay and follow the connected company analysis, news, and investor updates for Quest Diagnostics Incorporated.
WEBVTT 00:00:00.031 -- 00:00:04.516 Welcome to the Quest Diagnostics first quarter 2026 conference call. 00:00:04.516 -- 00:00:07.039 At the request of the company, this call is being recorded. 00:00:07.039 -- 00:00:11.223 The entire contents of this call, including the presentation and question and answer 00:00:11.223 -- 00:00:15.608 session that will follow, are the copyrighted property of Quest Diagnostics with all 00:00:15.608 -- 00:00:20.573 rights reserved. Any redistribution, retransmission, or rebroadcast of this call in any 00:00:20.573 -- 00:00:25.777 form without written consent of Quest Diagnostics is strictly prohibited. 00:00:25.859 -- 00:00:30.517 Now I'd like to turn the conference over to Dan Hammerly, interim vice president of investor 00:00:30.517 -- 00:00:34.821 relations for Quest Finastics. Please go ahead. 00:00:35.445 -- 00:00:40.813 Thank you and good morning. I'm joined by Jim Davis, our chairman, chief executive officer 00:00:40.813 -- 00:00:44.899 and president, and Sam Samad, our chief financial officer. 00:00:44.899 -- 00:00:50.447 During this call, we may make forward-looking statements and we'll discuss non-GAAP measures. 00:00:50.447 -- 00:00:55.475 We provide a reconciliation of non-GAAP measures to comparable GAAP measures in the table 00:00:55.475 -- 00:01:01.433 to our earnings press release actual results may differ materially from those projected. 00:01:01.433 -- 00:01:06.360 Risks and uncertainties that may affect Quest Diagnostics' future results include, but 00:01:06.360 -- 00:01:12.308 are not limited to, those described in our most recent annual report on Form 10-K 00:01:12.308 -- 00:01:17.315 and subsequently quarterly filed reports on Form 10-Q and current 00:01:17.315 -- 00:01:23.083 reports on Form 8-K. For this call, r...